As the curtains close on Fierce JPM Week in San Francisco, we're thrilled to invite you to an immersive continuation of the experience – the Fierce JPM Week Virtual Event, taking place next week from January 16-18th.
Register now to catch up on sessions from our live event. And enjoy exclusive presentations during this complimentary virtual event.
Don’t miss this annual event, brought to you by the award-winning Fierce editorial team, and hear from prominent executives from Teva, Daiichi Sankyo, Vir Biotechnology, BMS, Merck and more!
|
|
|
| A Look at Biopharma M&A and Shifting Deal Dynamics Crossovers, Megarounds and IPOs: Biotechs Always Find a WayDriving BioPharma Digital Transformation: Avoiding Pitfalls to Achieve Breakthrough SuccessExploring the Inflation Reduction Act: Pharma's Legal Battles and the Future of Innovation Advancements and Challenges in Cell & Gene Therapy ManufacturingOncology's Next Frontier: ADCs, Radiopharma and the Future of Cancer TreatmentRevolutionizing Healthcare: The Impact of AI Disruption in Clinical Trials |
| Richard Francis, CEO, Teva Pharmaceuticals Ken Keller, Chairman of the Board, President and CEO,Global Head Oncology Business, Daiichi Sankyo, Inc.Myrtle Potter, President, CEO and Chairman, Sumitomo Pharma America Gaurav Marya, Head of Strategic Business Unit for Life Sciences, CognizantSamer Ansari, Head of Data, Digital & Technology, Oncology Business Unit, Takeda Greg Meyers,EVP, Chief Digital & Technology Officer, Bristol Myers SquibbHervé Hoppenot, President and CEO, Incyte Marianne De Backer, CEO and Director, Vir BiotechnologyRobert Plenge, EVP, Chief Research Officer, Head of Research, Bristol-Myers Squibb Elizabeth Naldi Jacob, Head of Oncology BD & Headquarters Transactions, Merck |
|
|
Thank You to Our Partners |
|
|
If you no longer wish to receive promotion on this event, simply unsubscribe.
Refer to our Privacy Policy.
Fierce Life Sciences is a division of Questex LLC.
685 3rd Ave 21st Floor New York, NY 10017 Contact Us
© 2022 Questex LLC. All Rights Reserved.
Reproduction in whole or in part is prohibited without written permission. |
|
|
|
